This series of six publications focuses on Key Issues in Ocular Surface Disease. It aims to support optometrists’ clinical reasoning and decision making abilities through interactive learning modules designed to give clinicians a structured process for the diagnosis and treatment of dry eye and other co-morbid ocular surface disorders.
Each case offers one hour of COPE certified continuing education credit. Upon successful completion of the examinations, participants are prompted to print their certificate and are responsible for uploading their credit to ARBO’s OE Tracker system.
Note: Participants are responsible for submitting copies for licensing requirements and maintaining copies for their professional records.
Key Issues in Ocular Surface Disease: Issue 1
- Diagnostic Challenges in Ocular Surface Disease, Derek Cunningham, OD, FAAO
- Allergic Conditions Affecting the Ocular Surface, Mile Brujic, OD, FAAO
- Differentiate various forms of ocular surface disease, including dry eye disease, ocular allergy, and infectious conjunctivitis, based on patient history, clinical presentation, and diagnostic testing.
- Recognize comorbidities in patients with ocular surface disease and formulate the appropriate treatment strategy.
- Identify the most common causes of acute and chronic allergic conjunctivitis.
- Design an appropriate course of management for patients with acute allergic conjunctivitis.
COPE: #52517-AS Event: #112918
View KIOSD Issue 1 Take KIOSD Issue 1 Quiz
Key Issues in Ocular Surface Disease: Issue 2
- Inflammation in Dry Eye Disease, Blair Lonsberry, OD, FAAO
- Communicating with Dry Eye Patients, Whitney Hauser, OD
- Describe the pathophysiology of DED, including the role of inflammation and prevention.
- Implement basic DED diagnosis and management into daily practice.
- Know how to screen for DED in everyday practice.
- Improve compliance and outcomes by skillful communication with patients.
COPE: #53156-AS Event: #113211
View KIOSD Issue 2 Take KIOSD Issue 2 Quiz
Key Issues in Ocular Surface Disease: Issue 3
- Algorithms as Management Tools in the Treatment of Dry Eye Disease, Douglas K. Devries, OD
- Contact Lens Wear and the Ocular Surface, Anna F. Ablamowicz, OD, FAAO
- Explain the methodology and function of an algorithm for DED management.
- Describe the advantages and limitations of practice guidelines, and describe the ways to incorporate algorithms effectively into clinical practice.
- Counsel patients regarding interactions between contact lenses and the tear film and their implications.
- Identify and better manage dry eye in contact lens-wearing patients.
COPE: #53893-AS Event: #113601
View KIOSD Issue 3 Take KIOSD Issue 3 Quiz
Key Issues in Ocular Surface Disease: Issue 4
- Ocular Surface Disease in Glaucoma Patients, Leo Semes, OD
- Dry Eye Disease in Ocular Surgery Patients, Walter Whitley, OD, FAAO
- Identify underlying causes of OSD among ocular hypertension/glaucoma patients.
- Design a treatment plan to manage OSD in ocular hypertension/glaucoma patients.
- Identify issues specific to DED patients undergoing surgery.
- Better manage DED patients before and after surgery.
COPE: #54454-AS Event: #113936
View KIOSD Issue 4 Take KIOSD Issue 4 Quiz
Key Issues in Ocular Surface Disease: Issue 5
- Dry Eye Symptomatology and Pathophysiology: New Understandings, Kelly K. Nichols, OD, MPH, PhD, FAAO
- Examination and Imaging for Dry Eye Disease Evaluation, Katherine M. Mastrota, MS, OD, FAAO
- Use patient-centric classification scheme to guide critical decisions in the diagnosis and treatment of DED.
- Outline the core mechanics and the vicious inflammatory circle that underlie the initiation and perpetuation of DED.
- Understand the role of the melbomian glands in ocular surface health and disease.
- Better assess melbomian structure and function in everyday practice.
COPE: #55078-AS Event: #114217
View KIOSD Issue 5 Take KIOSD Issue 5 Quiz
Key Issues in Ocular Surface Disease: Issue 6
- Nonpharmaceutical Therapies for Dry Eye Disease Milton M. Hom, OD, FAAO
- Systematic Autoimmunity and Dry Eye Disease, Jillian Ziemanski, OD, MS, FAAO
- Broaden use of nonpharmaceutical modalities for DED treatment.
- Describe non-drop pipeline therapies that may be available in the near future.
- Suspect and diagnose autoimmune disease in patients with DED.
- Manage DED in patients with underlying systemic disorder.
COPE: #55690-AS Event: #114637
View KIOSD Issue 6 Take KIOSD Issue 6 Quiz